Diagnostic Testing in the US Ancillary Hospital Locations (ER, OR, ICU)
US$ 10,000.00
... among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals closer to the patient. Market Segmentation Analysis ... during the next ten years. Design criteria for POC testing products. Alternative business expansion strategies. Potential market entry barriers ...
May 2013
973 pages
Microbiology in Europe: Market Segment Forecasts and Supplier Shares
US$ 15,760.00
... opportunities and developing effective business strategies. The report provides market segmentation analysis of over 70 diseases and viruses in five countries, assessment of ... the main driving forces behind the growth of this dynamic market is continuous spread of AIDS, which remains the world’s major health ...
May 2013
1600 pages
Nucleic Acid Testing in Europe: Market Segment Forecasts and Supplier Shares
US$ 15,760.00
... next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies ...
May 2013
970 pages
Transfusion Diagnostics in Europe: Market Segment Forecasts and Supplier Shares
US$ 15,760.00
... from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than ...
May 2013
600 pages
Tumor Markers in Europe: Market Segment Forecasts and Supplier Shares
US$ 15,760.00
... and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends in France, Germany, ... diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and ...
May 2013
820 pages
Diagnostic Testing in France: Market Segment Forecasts and Supplier Shares
US$ 3,880.00
... Planning Group provides an overview of the French diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers ... volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation Drugs of Abuse Endocrine Hematology and ...
May 2013
58 pages
Diagnostic Testing in Germany: Market Segment Forecasts and Supplier Shares
US$ 3,880.00
... Planning Group provides an overview of the German diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers ... volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation Drugs of Abuse Endocrine Hematology and ...
May 2013
61 pages
Diagnostic Testing in Italy: Market Segment Forecasts and Supplier Shares
US$ 3,880.00
... from Venture Planning Group provides an overview of the Italian diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation ...
May 2013
57 pages
Diagnostic Testing in Japan: Market Segment Forecasts and Supplier Shares
US$ 3,880.00
... from Venture Planning Group provides an overview of the Japanese diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation ...
May 2013
60 pages
Diagnostic Testing in Spain: Market Segment Forecasts and Supplier Shares
US$ 3,880.00
... from Venture Planning Group provides an overview of the Spanish diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation ...
May 2013
56 pages
Diagnostic Testing in the UK: Market Segment Forecasts and Supplier Shares
US$ 3,880.00
This new report from Venture Planning Group provides an overview of the UK diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer ...
May 2013
64 pages
Diagnostic Testing in the US: Market Segment Forecasts and Supplier Shares
US$ 4,320.00
This new report from Venture Planning Group provides an overview of the US diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer ...
May 2013
101 pages
UK Tumor Marker Testing Market Innovations, Trends and Opportunities for Suppliers
US$ 4,880.00
... shares) $1,950. Highlights Comprehensive 575-page analysis of the UK tumor marker testing market. Major issues pertaining to the UK laboratory practice, as well as ... , lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for ...
May 2013
575 pages
US Tumor Marker Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers
US$ 7,760.00
... shares) $3,450. Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as ... , lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for ...
May 2013
620 pages
UK Blood Banking Market Outlook: Innovations, Trends and Opportunities for Suppliers
US$ 4,880.00
This report presents a comprehensive analysis of the UK blood banking market, including: Major issues pertaining to the UK blood banking practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Ten-year volume ...
May 2013
422 pages
French Clinical Chemistry and Immunodiagnostic Market Outlook: Innovations, Trends and Opportunities for Suppliers
US$ 4,880.00
... markets, including: Major issues pertaining to the French clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, social ... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ...
May 2013
542 pages
German Clinical Chemistry and Immunodiagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers
US$ 4,880.00
... markets, including: Major issues pertaining to the German clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, social ... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ...
May 2013
578 pages
Italian Clinical Chemistry and Immunodiagnostic Market Outlook: Innovations, Trends and Opportunities for Suppliers
US$ 4,880.00
... markets, including: Major issues pertaining to the Italian clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, social ... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ...
May 2013
561 pages
